Doug Fulling, MA, and Andrew Cournoyer, MBA, discuss how patients could benefit from payers learning more about a new drug by ...

Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and ...

A cross-sectional study found that static pain measures could be useful for predicting fatigue severity in patients with ...

Researchers of a new study explore what areas of chronic lymphocytic leukemia (CLL) treatment and care are important to ...

Rising COVID-19 cases are attributed to travel, heatwaves, and new variants; an analysis highlights challenges in states not ...

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School, discusses ways ...

Jessilin Quint, OD, MBA, FAAO, and Rebecca Petris discussed the different presentations of dry eye and how patients can ...

A new report provided updated figures estimated the birth prevalence of spinal muscular atrophy (SMA) in the US.

Andrew Cournoyer discusses how introducing payers into clinical trials earlier could help make the introduction of new ...

Patients with atopic dermatitis who use oral corticosteroids for more than 90 days have a slightly increased risk of adverse ...

The Commonwealth Fund scorecard ranks Mississippi, Texas, Nevada, and Oklahoma among the poorest-performing states overall ...

A leading oncologist explores promising new breast cancer therapies in the drug development pipeline and advises healthcare ...